What lessons can be learned from γδ T cell-based cancer immunotherapy trials?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Published:2012-12-17 Issue:1 Volume:10 Page:35-41
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Fournié Jean-Jacques,Sicard Hélène,Poupot Mary,Bezombes Christine,Blanc Amandine,Romagné François,Ysebaert Loic,Laurent Guy

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/cmi201239.pdf

Reference65 articles.

1. Meraviglia S, Caccamo N, Guggino G, Tolomeo M, Siragusa S, Stassi G et al. Optimizing tumor-reactive γδ T cells for antibody-based cancer immunotherapy. Curr Mol Med 2010; 10: 719–726.

2. Kabelitz D . Human γδ T lymphocytes for immunotherapeutic strategies against cancer. F1000 Med Rep 2010; 2: 45.

3. Kunzmann V, Wilhelm M . Adjuvant zoledronic acid for breast cancer: mechanism of action? Lancet Oncol 2011; 12: 991–992.

4. Hannani D, Ma Y, Yamazaki T, Dechanet-Merville J, Kroemer G, Zitvogel L . Harnessing γδ T cells in anticancer immunotherapy. Trends Immunol 2012; 33: 199–206.

5. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T . Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999; 96: 6879–6884.

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of gamma/delta T cells for solid tumor immunotherapy;Frontiers in Immunology;2024-08-26

2. Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-08

3. Chirality-Dependent Reprogramming of Macrophages;ACS Nano;2024-07-16

4. The therapeutic role of γδT cells in TNBC;Frontiers in Immunology;2024-06-12

5. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3